Clinical Drug Experience Knowledgebase

Acquired Immunodeficiency Syndrome (Phase 2)

Adenocarcinoma (Phase 2)

Albuminuria (Phase 2)

Anemia, Sickle Cell (Phase 2)

Blood Coagulation Disorders (Phase 3)

Breast Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 2)

Cystic Fibrosis (Phase 3)

Fibrosis (Phase 3)

Hemostatic Disorders (Phase 3)

Hepatitis C (Phase 3)

HIV Infections (Phase 2)

Hodgkin Disease (Phase 3)

Immunoblastic Lymphadenopathy (Phase 3)

Infarction (Phase 3)

Infections (Phase 2)

Leukemia (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Liver Neoplasms (Phase 2)

Lung Diseases (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, T-Cell (Phase 3)

Lymphopenia (Phase 1)

Monoclonal Gammopathy of Undetermined Significance (Phase 3)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Mycoses (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Myocardial Infarction (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Hip (Phase 3)

Paraproteinemias (Phase 3)

Parkinson Disease (Phase 2)

Pleural Effusion (Phase 1)

Pleural Effusion, Malignant (Phase 1)

Polyneuropathies (Phase 3)

Preleukemia (Phase 3)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Sclerosis (Phase 3)

Shock (Phase 3)

Shock, Hemorrhagic (Phase 3)

Sinusitis (Phase 3)

Syndrome (Phase 3)

Thrombocytopenia (Phase 3)

Urticaria (Phase 4)